Insulin Degludec — Discount Pricing
Insulin Degludec is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.
Insulin Degludec Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Discount pricing may be available |
| Typical Retail | $102.00 |
Discount pricing may be available; confirm the price with the dispensing pharmacy.
About Insulin Degludec
Insulin Degludec is a prescription medication. Ask your doctor if Insulin Degludec is right for you.
How to Check Insulin Degludec Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
Insulin Degludec at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Diabetes & Metabolism
About Insulin Degludec
Insulin degludec, often known by its brand name Tresiba, is a long-acting insulin crucial for many living with diabetes. It provides a steady, once-daily dose to help manage blood sugar levels effectively. At TheDrugClub, we understand the importance of affordable access to essential medications like insulin degludec, helping our members save on their prescription costs.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
What Insulin Degludec is approved for (FDA label)
Insulin Degludec is indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus. Limitations of Use • Not recommended for the treatment of diabetic ketoacidosis. Insulin Degludec is a long-acting human insulin analog indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus ( 1 ). Limitations of Use: • Not recommended for the treatment of diabetic ketoacidosis.
Source: Read the full FDA label on DailyMed. Label effective date: June 3, 2024.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.